Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial
Academic Article
Publication Date:
2019
Abstract:
Borderline Personality Disorder (BPD) is a complex and debilitating disorder, characterized by deficits in metacognition and emotion dysregulation. The "gold standard" treatment for this disorder is psychotherapy with pharmacotherapy as an adjunctive treatment to target state symptoms. The present randomized clinical trial aims to assess the clinical and neurobiological changes following Metacognitive Interpersonal Therapy (MIT) compared with Structured Clinical Management (SCM) derived from specific recommendations in APA (American Psychiatric Association) guidelines for BPD.
CRIS type:
1.1 Articolo in rivista
Keywords:
Borderline personality disorder; Emotion dysregulation; Metacognition; Neuroimaging; Psychotherapy
List of contributors:
Magni, LAURA ROSA; Carcione, Antonino; Ferrari, Clarissa; Semerari, Antonio; Riccardi, Ilaria; Nicolo', Giuseppe; Lanfredi, Mariangela; Pedrini, Laura; Cotelli, Maria; Bocchio, Luisella; Pievani, Michela; Gasparotti, Roberto; Rossi, Roberta; Rossi, R; Magni, Lr; Lanfredi, M; Pedrini, L; Carcione, A; Semerari, A; Riccardi, I; Nicolo', G; Almici, M; Beneduce, R; Borsci, G; Caprioli, C; Nodari, M; Vita, A; Barlati, S; Laffranchini, L; Rillosi, L; Rossi, G; Bocchio, L; Cattaneo, A; Cattane, N; Tura, Gb; Bignotti, S; Speziali, M; Cotelli, M; Rosini, S; Gasparotti, R; Ambrosi, C; Mascaro, L; Corbo, D; Pievani, M; Quattrini, G; Bilotta, E; Colle, L; Conti, L; Fiore, D; Micheloni, A; Procacci, M; Silvestre, V.
Published in: